SKINOVATION PHARMACEUTICAL INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Skinovation Pharmaceutical Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Skinovation Pharmaceutical Inc Return On Equity for the quarter ending September 30, 2024 was 9.65 %, a 18.3% increase year-over-year.
  • Skinovation Pharmaceutical Inc annual Return On Equity for 2023 was 8.26 %, a 2.25% decline from 2022.
  • Skinovation Pharmaceutical Inc annual Return On Equity for 2022 was 8.44 %, a 4.74% decline from 2021.
  • Skinovation Pharmaceutical Inc annual Return On Equity for 2021 was 8.86 %, a 51.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 8.26 -0.19 -2.25% Jan 1, 2023 Dec 31, 2023
2022 8.44 -0.42 -4.74% Jan 1, 2022 Dec 31, 2022
2021 8.86 -9.46 -51.7% Jan 1, 2021 Dec 31, 2021
2020 18.3 +8.54 +87.3% Jan 1, 2020 Dec 31, 2020
2019 9.78 -0.62 -5.96% Jan 1, 2019 Dec 31, 2019
2018 10.4 -0.71 -6.39% Jan 1, 2018 Dec 31, 2018
2017 11.1 -0.59 -5.04% Jan 1, 2017 Dec 31, 2017
2016 11.7 -2.34 -16.7% Jan 1, 2016 Dec 31, 2016
2015 14.1 -2.27 -13.9% Jan 1, 2015 Dec 31, 2015
2014 16.3 -10.5 -39.2% Jan 1, 2014 Dec 31, 2014
2013 26.9 +27.6 Jan 1, 2013 Dec 31, 2013
2012 -0.78 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.